Recent studies have demonstrated that CXCR5 activity is essential for TB immune response (Gopal et al., 2013; Slight et al., 2013), and our results suggest that expression of this chemokine may be deficient in our most symptomatic subjects. Here, CXCR5 is linked to tuberculosis.